Evidence map›Paper›PMID 42200957›Full record

ArticlePharmacy (Basel, Switzerland)2026

Effect of Pharmacist-Led Educational Intervention on Switching to Generic Medicine Among Patients Using Brand-Name Medicines in Japan.

Tomohiko Tairabune, Terutaka Goto, Kentaro Yamazaki, Kenzo Kudo, Ken-Ichi Sako, Tomoji Maeda, Takeshi Chiba

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomohiko TairabuneRegina Pharmacy Jimbocho, Unimat Life Co, Ltd., 1F Tamura Building 3-2-4 Kanda-Jimbocho, Chiyoda-ku, Tokyo 101-0051, Japan.
Terutaka GotoDivision of Pharmacy, Unimat Life Co, Ltd., Unimat Aoyama Building 2-12-14 Minami-aoyama, Minato-ku, Tokyo 107-0062, Japan.
Kentaro YamazakiMayumi Pharmacy Shoto, Unimat Life Co, Ltd., 1F Matsuo Building 1-29-2 Shoto, Shibuya-ku, Tokyo 150-0046, Japan.
Kenzo KudoDivision of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cyo 028-3694, Japan.
Ken-Ichi SakoDepartment of Clinical Pharmacology, Nihon Pharmaceutical University,10281 Komuro, Ina-Machi, Kitaadachi-gun, Saitama 362-0806, Japan.ORCID 0000-0003-1486-5825
Tomoji MaedaDepartment of Clinical Pharmacology, Nihon Pharmaceutical University,10281 Komuro, Ina-Machi, Kitaadachi-gun, Saitama 362-0806, Japan.
Takeshi ChibaDepartment of Pharmacy, Juntendo University Hospital, 3-1-3 Hongo, Bunkyo-ku, Tokyo 113-8431, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of generic medicines (GEs) is being promoted to reduce healthcare costs. This study aims to evaluate the effect of a pharmacist-led educational intervention on the number of patients switching from brand-name medicines to GEs among patients who preferred brand-name products. Pharmacists provided a standardized explanation using pamphlets about GEs to patients who wished to use brand-name medicines and allocated time to answer questions. Basic knowledge about GEs (nine items) and perceptions of GE use (three items) were assessed before and after the intervention to determine whether changes influenced switching behavior. Between 1 March and 30 July 2025, 40 patients were enrolled in the analysis. Following the intervention, the number of patients using one or more brand-name medicines significantly decreased to 25. Knowledge and perceptions of GEs significantly increased after the intervention and were associated with an increased rate of switching to GEs. Binominal logistic regression analysis identified age ≥ 65 years as a strong factor associated with preference for brand-name medicines (OR, 16.45; 95% CI, 1.48-182.65;

Indexed as

brand-name medicineeducational interventiongeneric medicinepatientpharmacist

Identifiers

PMID42200957
PMCPMC13214643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.